CY1117855T1 - Διαδικασια για τη συνθεση των παραγωγων 3,6-διυδρο-1,3,5-τριαζινης - Google Patents

Διαδικασια για τη συνθεση των παραγωγων 3,6-διυδρο-1,3,5-τριαζινης

Info

Publication number
CY1117855T1
CY1117855T1 CY20161100394T CY161100394T CY1117855T1 CY 1117855 T1 CY1117855 T1 CY 1117855T1 CY 20161100394 T CY20161100394 T CY 20161100394T CY 161100394 T CY161100394 T CY 161100394T CY 1117855 T1 CY1117855 T1 CY 1117855T1
Authority
CY
Cyprus
Prior art keywords
procedure
triazine
dyhydro
producers
composition
Prior art date
Application number
CY20161100394T
Other languages
English (en)
Inventor
Stéphanie AUBOURG
Bernard Boudet
Daniel Cravo
Matthias Helmreich
Original Assignee
Poxel S.A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel S.A.S. filed Critical Poxel S.A.S.
Publication of CY1117855T1 publication Critical patent/CY1117855T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Νέα διαδικασία για τη σύνθεση των παραγώγων 3,6-διυδρο-1,3,5-τριαζίνης για τη θεραπευτική αντιμετώπιση των διαταραχών που συνδέονται με το σύνδρομο αντίστασης ινσουλίνης.
CY20161100394T 2008-05-23 2016-05-11 Διαδικασια για τη συνθεση των παραγωγων 3,6-διυδρο-1,3,5-τριαζινης CY1117855T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08009483 2008-05-23
PCT/EP2009/002997 WO2009141040A2 (en) 2008-05-23 2009-04-24 Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives
EP09749530.3A EP2300444B1 (en) 2008-05-23 2009-04-24 Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives

Publications (1)

Publication Number Publication Date
CY1117855T1 true CY1117855T1 (el) 2017-05-17

Family

ID=40791625

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100394T CY1117855T1 (el) 2008-05-23 2016-05-11 Διαδικασια για τη συνθεση των παραγωγων 3,6-διυδρο-1,3,5-τριαζινης

Country Status (21)

Country Link
US (1) US20110124860A1 (el)
EP (1) EP2300444B1 (el)
JP (1) JP5458093B2 (el)
KR (1) KR101618198B1 (el)
CN (1) CN102036970A (el)
AU (1) AU2009250149B2 (el)
BR (1) BRPI0912512B1 (el)
CA (1) CA2725011A1 (el)
CY (1) CY1117855T1 (el)
DK (1) DK2300444T3 (el)
EA (1) EA018921B1 (el)
ES (1) ES2571793T3 (el)
HR (1) HRP20160414T1 (el)
HU (1) HUE027532T2 (el)
IL (1) IL209198A (el)
MX (1) MX2010012741A (el)
PL (1) PL2300444T3 (el)
RS (1) RS54736B1 (el)
SI (1) SI2300444T1 (el)
WO (1) WO2009141040A2 (el)
ZA (1) ZA201009160B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2646422E (pt) 2010-12-01 2015-10-20 Poxel Separação de enantiómeros de derivados de triazina com utilização de ácido tartárico
CN105753801B (zh) * 2016-03-25 2018-06-01 浙江工业大学 一种均三嗪类化合物的制备方法
MX2020003243A (es) 2017-10-02 2020-09-18 Poxel Métodos para tratar la insuficiencia cardíaca con fracción de eyección preservada.
MX2020013210A (es) 2018-06-06 2021-02-26 Metavant Sciences Gmbh Metodos de tratamiento de sujetos que padecen diabetes con enfermedad renal cronica.
AU2019286326A1 (en) 2018-06-14 2020-12-10 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
CN114681464B (zh) * 2020-12-28 2024-07-09 南京理工大学 二甲双胍类似物在制备脑缺血再灌注损伤预防和治疗药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
JP4391422B2 (ja) * 2002-12-17 2009-12-24 浜理薬品工業株式会社 新規２，４−ジアミノ−１，３，５−トリアジン誘導体
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
DE102007054416A1 (de) * 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind

Also Published As

Publication number Publication date
BRPI0912512B1 (pt) 2018-09-11
KR20110013498A (ko) 2011-02-09
JP2011520930A (ja) 2011-07-21
CN102036970A (zh) 2011-04-27
HUE027532T2 (en) 2016-10-28
EP2300444A2 (en) 2011-03-30
EA201001828A1 (ru) 2011-04-29
PL2300444T3 (pl) 2016-08-31
CA2725011A1 (en) 2009-11-26
JP5458093B2 (ja) 2014-04-02
DK2300444T3 (en) 2016-05-23
KR101618198B1 (ko) 2016-05-04
US20110124860A1 (en) 2011-05-26
HRP20160414T1 (hr) 2016-05-20
RS54736B1 (sr) 2016-10-31
AU2009250149B2 (en) 2013-05-23
MX2010012741A (es) 2010-12-21
ZA201009160B (en) 2011-10-26
EP2300444B1 (en) 2016-04-13
EA018921B1 (ru) 2013-11-29
BRPI0912512A2 (pt) 2015-07-28
ES2571793T3 (es) 2016-05-26
AU2009250149A1 (en) 2009-11-26
IL209198A0 (en) 2011-01-31
SI2300444T1 (sl) 2016-10-28
WO2009141040A2 (en) 2009-11-26
WO2009141040A3 (en) 2010-01-21
IL209198A (en) 2013-11-28

Similar Documents

Publication Publication Date Title
CY1117855T1 (el) Διαδικασια για τη συνθεση των παραγωγων 3,6-διυδρο-1,3,5-τριαζινης
CY1121364T1 (el) Νεοι κυτταροστατικοι νουκλεοζιτες 7-δεαζαπουρινης
CY1118231T1 (el) Συνθεση λιποσωματος
MA32467B1 (fr) Derives de piperidinyle agonistes de gpcr
CY1116150T1 (el) Παραγωγα οξαδιαζολης και η χρηση τους ως ενισχυτων μεταβοτροπικου υποδοχεα γλουταμικου - 842
CY1119826T1 (el) Θεραπευτικες συνθεσεις που περιεχουν μακιτεντανη
CY1112724T1 (el) Παραγωγα ανθρακικης κουινουκλιδινης και ιατρικη συνθεση αυτων
CL2011000957A1 (es) Compuesto derivados de isoindolina sustituidos, inhibidores de citosinas tnf-a; composicion farmaceutica; utiles en el tratamiento del cancer.
MX2012003539A (es) Derivados de indol como moduladores de los canales de calcio activados por la liberacion de calcio (crac).
EA201170227A1 (ru) Имидазолкарбоксамиды
CL2010001496A1 (es) Compuestos derivados de (piridin-o pirimidin-)piperidina, agonistas de gpr119; composicion farmaceutica; y su uso para el tratamiento de la diabetes de tipo i, diabetes de tipo ii y enfermedades relacionadas tales como sindrome metabolico, dislipidemia y resistencia a la insulina.
ATE523507T1 (de) Piperidin-gpcr-agonisten
CR20110103A (es) Heteroarilos sustituidos
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
EA201070059A1 (ru) Композиции, содержащие ингибиторы триптофангидроксилазы
CL2012000937A1 (es) Compuestos heterociclicos espiro derivados de ciclohexano, inhibidores de hsl; procedimiento de preparacion; composicion farmaceutica que los comprende; uso del compuesto para el tratamiento de diabetes, sindrome metabolico, dislipidemia, aterosclerosis u obesidad.
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
CR11290A (es) Derivados de ciclopropilamida
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
CL2008000110A1 (es) Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos.
ECSP11011021A (es) Antagonistas de la via hedgehog de ftalazina disustituida
EA200801676A1 (ru) Комбинация производных триазина и сенсибилизаторов инсулина
EA201490268A1 (ru) Производные циклопропиламида, направленно действующие на гистаминовый н3-рецептор